NeuroMET mini symposium December 2017
15 Nov 2017
The second NeuroMET mini symposium
will be held at Charité - Universitätsmedizin Berlin, Berlin, Germany, on December 13, 2017.
The mini symposium is open to stakeholders from clinical laboratories, industry and academia, as well as Consortium members, and will be held as a satellite event to the Consortium meeting.
Following a brief introduction to the NeuroMET project, the symposium will include sessions on MRI, cognition and biomarkers.
Structural analysis of 7T MR images in the NeuroMet study
- Laura Göschel, Clinic for Neurology, Charité - Universitätsmedizin Berlin, Berlin
The Promise of MRI and MRS at Ultrahigh Field for Alzheimer’s Disease
- Itamar Ronen, CJ Gorter Center for High Field MRI Research, Leiden University Medical Center, Leiden
Metrology of categorical data in psychometrics
- Prof. Leslie Pendrill, RI:SE, Göteburg
Methodological limitations of protein quantification in the cerebrospinal fluid for early diagnosis of Alzheimer´s dementia
- Prof. Oliver Peters, Clinic for Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin
microRNA as Alzheimer's Disease biomarkers
- Carla Divieto, INRIM, Turin
Amyloid-beta(1-42) seeding activity as a biomarker in Alzheimer's Disease
- Christopher Secker & Lisa Diez, Neuroproteomics, Max-Delbrück-Center for Molecular Medicine, Berlin-Buch